Breaking News

Vetter’s New Clinical Mfg. Site Now Fully Integrated

Expands clinical capacity to address growing market demand.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Vetter, a global CDMO, has further invested in additional capacity to meet the growing global demand for clinical manufacturing for injectable drug products.   The company purchased a clinical manufacturing location in Rankweil, Austria, a year ago and the site has been modified to quality standards in aseptic fill and finish for drug-delivery systems. “With this additional facility we will further expand our capability for early clinical development for phase I and phase II drug candidates,” ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters